Jeffrey T L Smith

CIK 1604800 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 5, 2024 · Latest: Jan. 5, 2024

On this page

Insider at

Insider transactions

0 buys (P) 2 sells (S) Net: $-475,562 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 12, 2026 ZYME S 9,310 $22.67 $211,058 26,708 Direct -25.85% Disposed 17.6% (price as of 2026-08-20)
Jan. 5, 2026 ZYME S 10,538 $25.10 $264,504 18,352 Direct -36.48% Disposed 6.3% (price as of 2026-08-20)
Jan. 6, 2025 ZYME S 11,110 $14.92 $165,761 8,890 Direct -55.55% Disposed 78.8% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 12, 2026 ZYME Restricted Stock Unit Common Stock (17,666) 17,666 Disposed
Jan. 5, 2026 ZYME Restricted Stock Unit Common Stock (20,000) 20,000 Disposed
Jan. 10, 2025 ZYME Restricted Stock Unit Common Stock (53,000) 53,000 Acquired
Jan. 10, 2025 ZYME Stock Option (Right to Buy) Common Stock (79,000) $13.22 Jan. 9, 2035 79,000 Acquired
Jan. 6, 2025 ZYME Restricted Stock Unit Common Stock (20,000) 20,000 Disposed
Jan. 5, 2024 ZYME Restricted Stock Unit Common Stock (60,000) 60,000 Acquired
Jan. 5, 2024 ZYME Stock Option (Right to Buy) Common Stock (90,000) $10.56 Jan. 4, 2034 90,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 5, 2024 ZYME No securities are beneficially owned 0 Direct
Jan. 5, 2024 ZYME Stock Option (Right to Buy)→ Common Stock (188,000) 188,000 Direct